Just my opinions, and I'm probably a bit more cautious than most... the very post above mine paints an alternative view on why I could be totally wrong!
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-353
-
- There are more pages in this discussion • 665 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.025(2.15%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.107M | 947.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 199671 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 37944 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 200252 | 1.185 |
13 | 40944 | 1.180 |
11 | 106494 | 1.175 |
11 | 136676 | 1.170 |
6 | 55721 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 41020 | 2 |
1.195 | 66345 | 11 |
1.200 | 144652 | 17 |
1.205 | 106279 | 10 |
1.210 | 122829 | 9 |
Last trade - 10.51am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online